Other Liabilities, Noncurrent of CLOVER HEALTH INVESTMENTS, CORP. /DE from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly Other Liabilities, Noncurrent in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE Other Liabilities, Noncurrent for the quarter ending 31 Dec 2025 was $23,484,000, a 10% decline year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $23,484,000 -$2,599,000 -10% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $25,280,000 -$3,611,000 -12% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $28,860,000 +$6,568,000 +29% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $31,989,000 +$11,799,000 +58% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $26,083,000 +$2,921,000 +13% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $28,891,000 +$12,934,000 +81% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $22,292,000 +$6,229,000 +39% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $20,190,000 +$3,990,000 +25% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $23,162,000 +$6,969,000 +43% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $15,957,000 +$2,836,000 +22% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $16,063,000 +$2,995,000 +23% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $16,200,000 +$3,036,000 +23% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $16,193,000 +$2,098,000 +15% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $13,121,000 -$27,472,000 -68% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $13,068,000 -$15,624,000 -54% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $13,164,000 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $14,095,000 +$979,000 +7.5% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $40,593,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $28,692,000 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q4 2020 $13,116,000 31 Dec 2020 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.